X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
humans (26) 26
male (21) 21
female (17) 17
middle aged (14) 14
urology & nephrology (12) 12
adult (11) 11
aged (9) 9
transplantation (9) 9
end-stage renal disease (6) 6
dialysis (5) 5
glomerular filtration rate (5) 5
renal dialysis (5) 5
adolescent (4) 4
aged, 80 and over (4) 4
creatinine (4) 4
dose-response relationship, drug (4) 4
gastroenterology & hepatology (4) 4
kidney diseases (4) 4
kidney failure, chronic - therapy (4) 4
mutation (4) 4
nephrology (4) 4
abridged index medicus (3) 3
administration, oral (3) 3
blood pressure (3) 3
child (3) 3
chronic kidney-disease (3) 3
chronic-renal-failure (3) 3
genetics & heredity (3) 3
glomerular-filtration-rate (3) 3
haplotype analysis (3) 3
hemodialysis (3) 3
kidney failure, chronic - complications (3) 3
kidney transplantation (3) 3
kidneys (3) 3
liver (3) 3
mckd1 (3) 3
medicine, general & internal (3) 3
prospective studies (3) 3
recombination (3) 3
risk factors (3) 3
time factors (3) 3
treatment outcome (3) 3
young adult (3) 3
acute renal failure (2) 2
anaemia (2) 2
anemia (2) 2
angiotensin (2) 2
animals (2) 2
atrial fibrillation (2) 2
biopsy (2) 2
breath tests (2) 2
c-oxidase deficiency (2) 2
care and treatment (2) 2
cera (2) 2
chronic disease (2) 2
chronic kidney disease (2) 2
ckd (2) 2
ckd stage (2) 2
clearance (2) 2
clinical trials (2) 2
codon, nonsense (2) 2
complications and side effects (2) 2
creatinine - urine (2) 2
cresols - metabolism (2) 2
darbepoetin alfa (2) 2
deficiency (2) 2
diabetes (2) 2
diabetes mellitus (2) 2
diagnosis (2) 2
dialysis patients (2) 2
dietary supplements (2) 2
dna, mitochondrial - genetics (2) 2
double-blind method (2) 2
dyspepsia (2) 2
encephalopathy (2) 2
erythropoietin (2) 2
erythropoietin - analogs & derivatives (2) 2
erythropoietin - therapeutic use (2) 2
gastric emptying (2) 2
genetic aspects (2) 2
glucose (2) 2
health aspects (2) 2
heart diseases (2) 2
hematinics (2) 2
hematinics - therapeutic use (2) 2
improvement (2) 2
infant, newborn (2) 2
insulin (2) 2
kidney diseases - complications (2) 2
kidney diseases - therapy (2) 2
kidney failure, chronic - physiopathology (2) 2
kidney transplantation - methods (2) 2
kinetics (2) 2
lactic-acidosis (2) 2
leigh-syndrome (2) 2
mdrd nomogram (2) 2
measurement (2) 2
medical laboratory technology (2) 2
metabolism, inborn errors - diagnosis (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Kidney Diseases, ISSN 0272-6386, 2015, Volume 66, Issue 1, pp. 91 - 98
Background Use of vitamin K antagonists for the prevention of stroke and systemic embolism in dialysis patients with nonvalvular atrial fibrillation is... 
Nephrology | dosing guideline | Hemodialysis | pharmacodynamics | rivaroxaban | anticoagulant | stroke | dose finding | dose adjustment | atrial fibrillation | end-stage renal disease (ESRD) | area under the curve (AUC) | pharmacokinetics | anti-FXa activity | METAANALYSIS | end- stage renal disease (ESRD) | PROTHROMBIN TIME | WARFARIN | ORAL ANTICOAGULANTS | ANTI-XA ASSAY | UROLOGY & NEPHROLOGY | Thiophenes - therapeutic use | Thiophenes - adverse effects | Area Under Curve | Humans | Half-Life | Male | Thiophenes - administration & dosage | Morpholines - blood | Thiophenes - blood | Factor Xa Inhibitors - administration & dosage | Thrombophilia - etiology | Dose-Response Relationship, Drug | Rivaroxaban | Factor Xa Inhibitors - blood | Thromboembolism - prevention & control | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Thrombophilia - drug therapy | Administration, Oral | Morpholines - administration & dosage | Atrial Fibrillation - complications | Factor Xa Inhibitors - pharmacokinetics | Kidney Failure, Chronic - therapy | Thiophenes - pharmacokinetics | Factor Xa Inhibitors - therapeutic use | Factor Xa Inhibitors - adverse effects | Kidney Failure, Chronic - complications | Hemorrhage - chemically induced | Morpholines - pharmacokinetics | Drug Monitoring | Renal Dialysis | Index Medicus
Journal Article
International Urology and Nephrology, ISSN 0301-1623, 2/2012, Volume 44, Issue 1, pp. 207 - 212
European as well as US guidelines recommend the Modification of Diet in Renal Disease (MDRD) formula to determine the glomerular filtration rate (GFR) and,... 
End-stage renal disease | Nephrology | Medicine & Public Health | Urology/Andrology | CKD stage | MDRD nomogram
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 12/2010, Volume 25, Issue 12, pp. 4009 - 4017
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 11/2008, Volume 23, Issue 11, pp. 3654 - 3661
Journal Article
Journal of the American Society of Hypertension, ISSN 1933-1711, 08/2018, Volume 12, Issue 8, pp. 627 - 632
Individualized weighing of the risk benefit of anticoagulation is recommended in patients with atrial fibrillation (AF) who have low established risk scores... 
atrial fibrillation | Arterial stiffness | pulse wave velocity | augmentation index | STROKE | CARDIOVASCULAR EVENTS | RISK | PERIPHERAL VASCULAR DISEASE | AORTIC STIFFNESS
Journal Article
Annals of Transplantation, ISSN 1425-9524, 08/2017, Volume 22, pp. 524 - 531
Background: Hypomagnesemia is associated with a disturbed glucose metabolism. Insulin hypo-secretion predicts diabetes in the general population and in... 
Magnesium | Glucose metabolism disorders | Insulin | Kidney transplantation | SURGERY | DEPENDENT DIABETES-MELLITUS | POSTTRANSPLANTATION | SENSITIVITY | RISK | Kidney Transplantation | RECIPIENTS | TRANSPLANTATION | Glucose Metabolism Disorders | DOUBLE-BLIND | RESISTANCE | TACROLIMUS | GLUCOSE-TOLERANCE | HYPOMAGNESEMIA
Journal Article
Journal Article
by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Bakris, George and Correa-Rotter, Ricardo and Hou, Fan-Fan and Hou, Fanfan and Kitzman, Dalane W and Kohan, Donald and Makino, Shinya and Makino, Hirofumi and McMurray, John J V and Melnick, Joel Z and Miller, Michael G and Miller, Alan and Miller, Steven and Pergola, Pablo E and Pergola, Pablo and Perkovic, Vlado and Tobe, Sheldon and Yi, Joo Hark and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Maffei, Laura and Juncos, Luis and de Arteaga, Javier and Greloni, Gustavo and Farias, Eduardo and Zucchini, Alfredo and Vogel, Daniel and Cusumano, Ana and Santos, Juan and Fraenkel, Margaret and Gallagher, Martin and Davis, Tim and Acharya, Shamasunder and Cooke, Duncan and Suranyi, Michael and Roger, Simon and Toussaint, Nigel and Pollock, Carol and Chan, Doris and Stranks, Stephen and MacIsaac, Richard and Endre, Zoltan and Schmidt, Alice and Schmidt, Rebecca and Prager, Rudolf and Mayer, Gert and Warling, Xavier and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Costa e Forti, Adriana and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Moura Neto, Jose Andrade and Deboni, Luciane and de Lourdes Noronha, Irene and Cercato, Cintia and Prompt, Carlos Alberto and Zanella, Maria and Rassi, Nelson and D'Avila, Domingos and Milagres, Rosangela and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Amodeo, Celso and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Bajaj, Harpreet Singh and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Tam, Paul and Rabbat, Christian and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Munoz, Rodrigo and ... and SONAR Comm Investigators and SONAR Committees and Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | ENDOTHELIN | ALBUMINURIA | NEPHROPATHY | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Serum Albumin, Human - urine | Young Adult | Aged, 80 and over | Adult | Female | Diabetic Nephropathies - prevention & control | Endothelin A Receptor Antagonists - therapeutic use | Diabetic Nephropathies - urine | Glomerular Filtration Rate | Double-Blind Method | Endothelin A Receptor Antagonists - administration & dosage | Administration, Oral | Treatment Outcome | Creatinine - urine | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - prevention & control | Atrasentan - therapeutic use | Creatinine - blood | Aged | Atrasentan - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Renal Insufficiency, Chronic - urine | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Randomization | Renin | Motivation | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 09/2000, Volume 38, Issue 9, pp. 3511 - 3512
Journal Article
16.